COSCIENS Biopharma (CSCI) Total Debt

Annual Total Debt

$1.70 M
-$234.80 K-12.17%

December 1, 2023


Summary


Performance

CSCI Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCSCIbalance sheetmetrics:

Quarterly Total Debt

$1.62 M
-$71.00 K-4.21%

September 1, 2024


Summary


Performance

CSCI Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCSCIbalance sheetmetrics:

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

CSCI Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.2%-4.7%
3 y3 years-27.3%-4.7%
5 y5 years+263.3%-4.7%

CSCI Total Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.4%at low-22.2%+1.5%
5 y5-year-32.6%at low-35.8%+1.5%
alltimeall time-73.3%+2287.3%-74.7%+2740.1%

COSCIENS Biopharma Total Debt History

DateAnnualQuarterly
Sep 2024
-
$1.62 M(-4.2%)
Jun 2024
-
$1.69 M(+6.0%)
Mar 2024
-
$1.59 M(-6.1%)
Dec 2023
$1.70 M(-12.2%)
$1.70 M(-1.7%)
Sep 2023
-
$1.72 M(-6.3%)
Jun 2023
-
$1.84 M(-1.7%)
Mar 2023
-
$1.87 M(-3.0%)
Dec 2022
$1.93 M(-7.1%)
$1.93 M(+8.5%)
Sep 2022
-
$1.78 M(-8.5%)
Jun 2022
-
$1.94 M(-5.8%)
Mar 2022
-
$2.06 M(-0.6%)
Dec 2021
$2.08 M(-10.9%)
$2.08 M(-5.4%)
Sep 2021
-
$2.20 M(-5.0%)
Jun 2021
-
$2.31 M(+0.2%)
Mar 2021
-
$2.31 M(-1.0%)
Dec 2020
$2.33 M(-7.4%)
$2.33 M(+4.2%)
Sep 2020
-
$2.24 M(-0.5%)
Jun 2020
-
$2.25 M(+0.3%)
Mar 2020
-
$2.24 M(-10.9%)
Dec 2019
$2.52 M(+439.4%)
$2.52 M(-4.2%)
Sep 2019
-
$2.63 M(-3.7%)
Jun 2019
-
$2.73 M(-1.9%)
Mar 2019
-
$2.78 M(+495.7%)
Dec 2018
$466.50 K(-61.6%)
$466.50 K(-34.3%)
Sep 2018
-
$709.80 K(-16.5%)
Jun 2018
-
$850.50 K(-17.3%)
Mar 2018
-
$1.03 M(-15.3%)
Dec 2017
$1.21 M(-35.5%)
$1.21 M(-18.5%)
Sep 2017
-
$1.49 M(-7.3%)
Jun 2017
-
$1.60 M(-7.1%)
Mar 2017
-
$1.73 M(-8.3%)
Dec 2016
$1.88 M(-41.2%)
$1.88 M(-35.0%)
Sep 2016
-
$2.90 M(-6.2%)
Jun 2016
-
$3.09 M(-5.1%)
Mar 2016
-
$3.25 M(+1.6%)
Dec 2015
$3.20 M(+7.2%)
$3.20 M(-9.0%)
Sep 2015
-
$3.52 M(-6.1%)
Jun 2015
-
$3.75 M(+8.9%)
Mar 2015
-
$3.44 M(+15.1%)
Dec 2014
$2.99 M(+3.1%)
$2.99 M(-10.6%)
Sep 2014
-
$3.34 M(-9.6%)
Jun 2014
-
$3.69 M(+24.3%)
Mar 2014
-
$2.97 M(+2.5%)
Dec 2013
$2.90 M(+211.2%)
$2.90 M(+273.2%)
Sep 2013
-
$776.40 K(-3.1%)
Jun 2013
-
$801.50 K(-28.8%)
Mar 2013
-
$1.13 M(+20.9%)
Dec 2012
$931.30 K(-12.0%)
$931.30 K(-16.9%)
Sep 2012
-
$1.12 M(+1.8%)
Jun 2012
-
$1.10 M(+5.4%)
Mar 2012
-
$1.05 M(-1.3%)
Dec 2011
$1.06 M(-37.5%)
$1.06 M(-31.7%)
Sep 2011
-
$1.55 M(-8.3%)
Jun 2011
-
$1.69 M(-1.4%)
Mar 2011
-
$1.71 M(+1.2%)
Dec 2010
$1.69 M
$1.69 M(+1.5%)
DateAnnualQuarterly
Sep 2010
-
$1.67 M(+0.4%)
Jun 2010
-
$1.66 M(-4.8%)
Mar 2010
-
$1.75 M(+1.2%)
Dec 2009
$1.72 M(+23.8%)
$1.73 M(+31.7%)
Sep 2009
-
$1.31 M(+6.2%)
Jun 2009
-
$1.23 M(+6.3%)
Mar 2009
-
$1.16 M(-16.8%)
Dec 2008
$1.39 M(-14.4%)
$1.40 M(-3.4%)
Sep 2008
-
$1.44 M(-5.8%)
Jun 2008
-
$1.53 M(-0.8%)
Mar 2008
-
$1.55 M(-5.0%)
Dec 2007
$1.63 M(+301.0%)
$1.63 M(+67.3%)
Sep 2007
-
$973.40 K(+4.9%)
Jun 2007
-
$928.20 K(+136.7%)
Mar 2007
-
$392.10 K(-3.4%)
Dec 2006
$405.80 K(-14.6%)
$405.90 K(-22.1%)
Sep 2006
-
$521.30 K(+13.2%)
Jun 2006
-
$460.60 K(+0.8%)
Mar 2006
-
$457.00 K(-3.8%)
Dec 2005
$475.00 K(-10.7%)
$475.10 K(-3.4%)
Sep 2005
-
$492.00 K(+2.2%)
Jun 2005
-
$481.60 K(-6.8%)
Mar 2005
-
$516.70 K(-2.9%)
Dec 2004
$532.20 K(+198.7%)
$532.20 K(+78.7%)
Sep 2004
-
$297.90 K(+106.7%)
Jun 2004
-
$144.10 K(-10.6%)
Mar 2004
-
$161.20 K(-9.7%)
Dec 2003
$178.20 K(-63.2%)
$178.50 K(-11.1%)
Sep 2003
-
$200.80 K(-48.1%)
Jun 2003
-
$386.80 K(-15.6%)
Mar 2003
-
$458.30 K(-5.3%)
Dec 2002
$483.70 K(+581.3%)
$484.00 K(+709.4%)
Sep 2002
-
$59.80 K(-9.7%)
Jun 2002
-
$66.20 K(+0.8%)
Mar 2002
-
$65.70 K(-7.7%)
Dec 2001
$71.00 K(-72.0%)
$71.20 K(-48.0%)
Sep 2001
-
$136.90 K(+67.2%)
Jun 2001
-
$81.90 K(-0.8%)
Mar 2001
-
$82.60 K(-67.4%)
Dec 2000
$253.40 K(-38.6%)
$253.60 K(+345.7%)
Sep 2000
-
$56.90 K(-90.6%)
Jun 2000
-
$607.60 K(+10.3%)
Mar 2000
-
$550.80 K(+33.0%)
Dec 1999
$412.90 K(+113.1%)
$414.20 K(+52.1%)
Sep 1999
-
$272.40 K(+301.8%)
Jun 1999
-
$67.80 K(-48.8%)
Mar 1999
-
$132.50 K(-32.1%)
Dec 1998
$193.80 K(-80.2%)
$195.00 K(-40.5%)
Sep 1998
-
$327.50 K(-69.9%)
Jun 1998
-
$1.09 M(-3.4%)
Mar 1998
-
$1.13 M(+15.2%)
Dec 1997
$977.10 K(-84.6%)
$978.30 K(-84.6%)
Sep 1997
-
$6.37 M(+4.7%)
Jun 1997
-
$6.08 M(-4.6%)
Mar 1997
-
$6.38 M
Dec 1996
$6.35 M
-

FAQ

  • What is COSCIENS Biopharma annual total debt?
  • What is the all time high annual total debt for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual total debt year-on-year change?
  • What is COSCIENS Biopharma quarterly total debt?
  • What is the all time high quarterly total debt for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly total debt year-on-year change?

What is COSCIENS Biopharma annual total debt?

The current annual total debt of CSCI is $1.70 M

What is the all time high annual total debt for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual total debt is $6.35 M

What is COSCIENS Biopharma annual total debt year-on-year change?

Over the past year, CSCI annual total debt has changed by -$234.80 K (-12.17%)

What is COSCIENS Biopharma quarterly total debt?

The current quarterly total debt of CSCI is $1.62 M

What is the all time high quarterly total debt for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly total debt is $6.38 M

What is COSCIENS Biopharma quarterly total debt year-on-year change?

Over the past year, CSCI quarterly total debt has changed by -$79.00 K (-4.66%)